S*********e
发帖数: 127 | 1 Thanks.
1.
Recommendations for the evaluation of specimen stability for flow cytometric
testing during drug development.
Brown L, Green CL, Jones N, Stewart JJ, Fraser S, Howell K, Xu Y, Hill CG,
Wiwi CA, White WI, O'Brien PJ, Litwin V.
J Immunol Methods. 2015 Mar;418:1-8. doi: 10.1016/j.jim.2015.01.008. Epub
2015 Feb 4. Review.
PMID: 25662815
Similar articles
Select item 20946898
2.
Recommendations for the validation of flow cytometric testing during drug
development: II assays.
O'Hara DM, Xu Y, Liang Z, Reddy MP, Wu DY, Litwin V.
J Immunol Methods. 2011 Jan 5;363(2):120-34. doi: 10.1016/j.jim.2010.09.036.
Epub 2010 Oct 11. Review.
PMID: 20946898
Similar articles
Select item 20655313
3.
Recommendations for the validation of flow cytometric testing during drug
development: I instrumentation.
Green CL, Brown L, Stewart JJ, Xu Y, Litwin V, Mc Closkey TW.
J Immunol Methods. 2011 Jan 5;363(2):104-19. doi: 10.1016/j.jim.2010.07.004.
Epub 2010 Jul 22. Review.
PMID: 20655313
Similar articles |
